Skip to content

Fourstreets

Active
Private limited companyfounded 2023active for 3 yearsBeloeillaan 2, 1180 Ukkel, BelgiumKBO/BCE: BE 0799.100.747
Summary

Fourstreets has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €27,414 and a net result of -€21,265. Equity is shrinking by about 27% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2028. Its solvency ranks better than 13% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
≈ €100,000turnover 2025, estimated
Equity
€27,414
Loss
-€21,265
Turnover estimated from the gross margin
Financial health
83 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
2025 accounts filed 45 days late
Why 83raises riskLast filed accounts filed 45 days late; 1 of the last 3 lateLoss of €21,265, the second in a row (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €304,428Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 16% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Weak
Solvency 34-5
equity 9.0% of total assets
Liquidity 55-4
short-term debt 4.0% · cash 4.3%
Profitability 18-18
return on assets -7.0%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.3%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.2%▼ -0.1 percentage points vs 09-2026
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.26, compared with 2.05 in 2024, below the usual 1.5; short-term debt: 4% and cash: 4.3% of total assets), and 91% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 13% on solvency, 31% on liquidity, 4% on profitability and 14% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 45 days late; 1 of the last 3 late
NBB · filings
lowers risk · Size: total assets €304,428
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Loss of €21,265, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
232425
2023 to 2025 · latest year -€21,265
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 20643 sector peers (2025).
NBB · sector comparison
Position among 20643 sector peers
Solvency
better than 13%
← weakest strongest →
raises risk · 2025 accounts filed 45 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-09-2026, 45 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 3 filings
Deviation from the deadline
2025
45 days late
2024
22 days early
2023
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 18 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (3 of the last 3 filed years within 53 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Weakest financial yearnet -€21,265
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

2025 annual accounts filed late (45 days) Filed on 14 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00512103.

Turnover
≈ €100,000
Estimated: probably between €69,000 and €170,000
Total assets
€304,428▼ 9.7%
2024 · €337,151
Net result
-€21,265▼ 354%
2024 · -€4,682
Working capital
€3,140▼ 77.7%
2024 · €14,069
Trend over the years

2023 to 2025, 3 financial years

The operating result turns negative in 2025: a loss of €5,597 after €8,146 in 2024, the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€5,597 2025 Net result-€21,265 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result-€205-€8,146-€5,597
Net result-€9,139below the sector's middle half--€4,682below the sector's middle half▲ 48.8%-€21,265below the sector's middle half▼ 354%
Equity€53,361within the sector's middle half-€48,679within the sector's middle half▼ 8.8%€27,414below the sector's middle half▼ 43.7%
Total assets€371,934within the sector's middle half-€337,151within the sector's middle half▼ 9.4%€304,428within the sector's middle half▼ 9.7%
Debt€318,573-€288,473▼ 9.4%€277,014▼ 4.0%
Working capital-€11,634below the sector's middle half-€14,069below the sector's middle half€3,140below the sector's middle half▼ 77.7%
Solvency14.3%below the sector's middle half-14.4%below the sector's middle half▲ 0.1pp9.0%below the sector's middle half▼ 5.4pp
Current ratio0.65below the sector's middle half-2.05within the sector's middle half▲ 1.401.26within the sector's middle half▼ 0.79
Return on assets (ROA)-2.5%below the sector's middle half--1.4%below the sector's middle half▲ 1.1pp-7.0%below the sector's middle half▼ 5.6pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €304,428
Fixed assets €289,144 ▼ 6.6%
Current assets €15,284 ▼ 44.4%
Equity and liabilities €304,428
Equity €27,414 ▼ 43.7%
Debt €277,014 ▼ 4.0%
Debt's share of the balance-sheet total rises from 85.6% to 91.0%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€14,924▼
2024 · €28,547
Cash flow
-€744▼
2024 · €15,719
Debt to equity
10.10▲
2024 · 5.93
ROE
-77.6%▼
2024 · -9.6%
Interest coverage
0.96▼
2024 · 2.24
Debt ≤ 1 year
€12,144▼
2024 · €13,417
Debt > 1 year
€262,614▼
2024 · €275,056
Income taxes
€116▲
2024 · €107
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,301 companies that looked in July 2024 the way this one looks now, 5.5% went bankrupt within 24 months and 92.5% are still going.

  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a small loss
5.5% went bankrupt
1.6% stopped otherwise
92.5% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,301 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€337,151€304,428▼
Fixed assets21/28€309,665€289,144▼
Intangible fixed assets21€265€104▼
Tangible fixed assets22/27€309,345€288,985▼
Land and buildings22€294,918€278,690▼
Plant, machinery and equipment23€9,605€7,391▼
Furniture and vehicles24€4,821€2,904▼
Financial fixed assets28€56€56=
Current assets29/58€27,486€15,284▼
Amounts receivable within one year40/41-€1,078
Trade receivables40-€220
Other amounts receivable41-€858
Cash at bank and in hand54/58€25,202€12,960▼
Deferred charges and accrued income490/1€2,284€1,246▼
Equity and liabilities
Total equity and liabilities10/49€337,151€304,428▼
Equity10/15€48,679€27,414▼
Contributions10/11€62,500€62,500=
Profit (loss) carried forward14-€13,821-€35,086▼
Amounts payable17/49€288,473€277,014▼
Amounts payable after more than one year17€275,056€262,614▼
Financial debts170/4€272,326€261,427▼
Other amounts payable178/9€2,730€1,188▼
Amounts payable within one year42/48€13,417€12,144▼
Current portion of amounts payable after more than one year42€10,442€10,899▲
Trade debts44€378€1,113▲
Suppliers440/4€378€1,113▲
Taxes, remuneration and social security45€198€132▼
Taxes450/3€198€132▼
Other amounts payable47/48€2,399-
Accrued charges and deferred income492/3-€2,256
Income statement Code20242025
Non-recurring operating income76A€421-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20,401€20,521▲
Other operating charges640/8€387€400▲
Gross operating margin9900€28,934€15,324▼
Operating profit (loss)9901€8,146-€5,597▼
Financial charges65/66B€12,721€15,552▲
Recurring financial charges65€12,721€15,552▲
Profit (loss) for the period before taxes9903-€4,575-€21,149▼
Income taxes67/77€107€116▲
Profit (loss) for the period9904-€4,682-€21,265▼
Profit (loss) for the period to be appropriated9905-€4,682-€21,265▼
Appropriation of the result
Profit (loss) to be appropriated9906-€13,821-€35,086▼
Profit (loss) brought forward from the previous period14P-€9,139-€13,821▼

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Non-recurring operating income76A-€421--
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,017€20,401€20,521▲ 0.6%
Other operating charges640/8€384€387€400▲ 3.2%
Gross operating margin9900€14,196€28,934€15,324▼ 47.0%
Operating profit (loss)9901-€205€8,146-€5,597-
Financial charges65/66B€8,843€12,721€15,552▲ 22.3%
Recurring financial charges65€8,843€12,721€15,552▲ 22.3%
Profit (loss) for the period before taxes9903-€9,048-€4,575-€21,149▼ 362%
Income taxes67/77€91€107€116▲ 8.1%
Profit (loss) for the period9904-€9,139-€4,682-€21,265▼ 354%
Profit (loss) for the period to be appropriated9905-€9,139-€4,682-€21,265▼ 354%
Line202320242025Change
Assets
Total assets20/58€371,934€337,151€304,428▼ 9.7%
Fixed assets21/28€350,714€309,665€289,144▼ 6.6%
Intangible fixed assets21€427€265€104▼ 60.8%
Tangible fixed assets22/27€350,287€309,345€288,985▼ 6.6%
Land and buildings22€332,546€294,918€278,690▼ 5.5%
Plant, machinery and equipment23€11,002€9,605€7,391▼ 23.1%
Furniture and vehicles24€6,739€4,821€2,904▼ 39.8%
Financial fixed assets28-€56€56=
Current assets29/58€21,220€27,486€15,284▼ 44.4%
Amounts receivable within one year40/41--€1,078-
Trade receivables40--€220-
Other amounts receivable41--€858-
Cash at bank and in hand54/58€20,695€25,202€12,960▼ 48.6%
Deferred charges and accrued income490/1€525€2,284€1,246▼ 45.5%
Equity and liabilities
Total equity and liabilities10/49€371,934€337,151€304,428▼ 9.7%
Equity10/15€53,361€48,679€27,414▼ 43.7%
Contributions10/11€62,500€62,500€62,500=
Profit (loss) carried forward14-€9,139-€13,821-€35,086▼ 154%
Amounts payable17/49€318,573€288,473€277,014▼ 4.0%
Amounts payable after more than one year17€285,719€275,056€262,614▼ 4.5%
Financial debts170/4€282,768€272,326€261,427▼ 4.0%
Other amounts payable178/9€2,951€2,730€1,188▼ 56.5%
Amounts payable within one year42/48€32,854€13,417€12,144▼ 9.5%
Current portion of amounts payable after more than one year42€10,005€10,442€10,899▲ 4.4%
Trade debts44€22,555€378€1,113▲ 195%
Suppliers440/4€22,555€378€1,113▲ 195%
Taxes, remuneration and social security45€91€198€132▼ 33.4%
Taxes450/3€91€198€132▼ 33.4%
Other amounts payable47/48€203€2,399--
Accrued charges and deferred income492/3--€2,256-
Line202320242025Change
Profit (loss) for the period9904-€9,139-€4,682-€21,265▼ 354%
+ Depreciation and write-downs630€14,017€20,401€20,521▲ 0.6%
Operating cash flow (approximation)€4,878€15,719-€744-
Investment in fixed assets (approximation)-€20,647€0▼ 100%
Change in cash-€4,507-€12,242-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-12-2025 micro format 14-09-2026 2026-00512103
31-12-2024 micro format 09-07-2025 2025-00248882
31-12-2023 micro format 30-08-2024 2024-00450101

Similar companies · same sector, comparable size

Of the 9,162 active companies whose main activity is general medical practice (NACE 86210), figures are known for 6,451. 3,870 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2023
VIERSTRAETE Annelien Marguerite
Director (not named in the articles) · since 06-03-2023
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2023, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
VIERSTRAETE Annelien Marguerite
  • Director (not named in the articles), from 06-03-2023 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 06-03-2023 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 06-03-2023 Incorporation · €62,500 · 100 shares

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 2 March 2023, Fourstreets was incorporated as a private limited company by one natural person, with a starting capital of €62,500.12 VIERSTRAETE Annelien Marguerite has served as director of the company since 2023.2 Total assets went from €371,934 in 2023 to €304,428 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 06-03-2023
  3. 3National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
14-09
NBB filing Annual accounts filed
financial year 2025 · micro format · 45 days late
2025
31-12
Financial Weakest financial yearnet -€21,265
Net result drops to -€21,265, the lowest in the series.
09-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Liquidity more than triplescurrent ratio 2.05
Current ratio from 0.65 to 2.05; short-term debt falls from €32,854 to €13,417.
30-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 30 days late
2023
06-03
Gazette deed Incorporation
Appointment: VIERSTRAETE Annelien Marguerite (director) · Founder · Founding capital11 facts ▸
  • Founder, VIERSTRAETE Annelien Marguerite
  • Other provision, “representation at deed, procuration sous signature privée” (deed in French)
  • Incorporation, “Fourstreets” (deed in French)
  • Founding capital, €62,500
  • Bank account, “société en formation, BE28 7320 6876 0220” (deed in French)
  • Other provision, “adoption of statutes” (deed in French)
  • General meeting, “comparant exerçant pouvoirs dévolus à assemblée générale” (deed in French)
  • Registered office clause, “1180 Bruxelles avenue de Beloeil 2” (deed in French)
  • Board rule, 1
  • Director appointment, VIERSTRAETE Annelien Marguerite (director (not named in the articles))
  • Pre-incorporation commitments, “takeover, engagements obligations et activités entreprises au nom et pour compte société en formation” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 1 deed read

Register details

Identification
Legal formPrivate limited company
Founded02-03-2023
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
68203Renting and operating of own or leased non-residential real estate, excluding land
86959Human health activities
Contact
E-mail annelien.vierstraete@outlook.com
Phone +32498113784
E-invoicing
Reachable via Peppol
Peppol ID 0208:0799100747
Also 9925:BE0799100747
Registered 28-04-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2023
registered office establishment The establishment unit on the map
Ground area
1,159 m²
Building footprint
609 m²
Building volume
7,861 m³
Parcel 21612D0338/00W002, Brussels · tallest building 16.3 m. Linked by address, not a title deed.
4 companies at this address See who is registered here
1 establishment unit
Fourstreets
Beloeillaan 2, 1180 UkkelGeneral medical practice
since 2023unit no. 2.342.307.894
1 parcel
Brussels 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
21612D0338/00W002 Brussels 1,159 m² 1 · 609 m² 16.2 m · 5
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“La pratique de l’ostéopathie dans tous ses champs d’application,se rapportant directement ou indirectement à la conception,l’organisation et…” (deed in French)
10 activities (deed in French)
  1. La pratique de l’ostéopathie dans tous ses champs d’application,se rapportant directement ou indirectement à la conception,l’organisation et le fonctionnement d’un cabinet d’ostéopathie en ce compris et de manière non exhaustive la collaboration avec d’autres disciplines médicales et/ou paramédicales dans le respect des prescriptions d’ordre déontologique
  2. La pratique de la kinésithérapie,la médecine générale ou toute autre activité médicale et paramédicale
  3. La mise en œuvre de toutes techniques paramédicales
  4. L'accomplissement de toutes prestations liées à la santé,à la prévention
  5. La vente de produits médicaux,sportif,nutritionnels et de bien-être
  6. Le travail en tant qu’entité médicale et paramédicale dans le domaine de la revalidation de patientèle ainsi que toute discipline susceptible d’améliorer la santé de l’individu
  7. L’exploitation de cabinets de kinésithérapie,la dispensation de cours,formations relevant de cette profession
  8. La rééducation,la gymnastique médicale,gymnastique pré- et postnatale
  9. Le massage et la physiothérapie
  10. La commercialisation,sous toutes ses formes,de biens de toute natures liés directement ou indirectement avec les activités susmentionnées

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
Fourstreets
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Bruxelles-Capitale, sièges administratifs,agences,ateliers,dépôts et succursales,tant en Belgique qu'à l'étranger” (deed in French)

deed of 06-03-2023

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
“Lorsque la société est administrée par plusieurs administrateurs, chaque administrateur agissant seul, peut accomplir tous les actes…”
“Est appelée aux fonctions d’administrateurs non statutaires pour une durée illimitée : - Madame VIERSTRAETE Annelien, prénommée, ici…”
Full text

Est appelée aux fonctions d’administrateurs non statutaires pour une durée illimitée : - Madame VIERSTRAETE Annelien, prénommée, ici présente et qui accepte. L’administrateur fait élection de domicile au siège de la société pour toutes les affaires relatives à l’ exercice de ce mandat. 5-Pouvoir de signature Le pouvoir de signature des administrateurs sera individuel pour tous actes et/ou engagements de la société. 6-Rémunération Le mandat d’administrateur pourra être rémunéré.

Board ruleHow the board is made up, meets and takes decisions.
“Avec ou sans limitation de durée, personnes physiques ou morales,actionnaires ou non” (deed in French)

deed of 06-03-2023

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“En rémunération des apports, 100” (deed in French)

deed of 06-03-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Friday of June at 18:00

deed of 06-03-2023

Oversight and winding up

Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor
Dissolution ruleWhen and by whom the company can be dissolved.
“Comme en matière de modification des statuts, assemblée générale” (deed in French)
“Assemblée générale délibérant formes modifications statuts” (deed in French)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“En vertu statuts si aucun autre désigné, administrateurs en fonction” (deed in French)

deed of 06-03-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Contrôle de la société, un ou plusieurs commissaires” (deed in French)
Other provision: “Assemblée générale par procédure écrite, toutes les décisions qui relèvent du pouvoir de l'assemblée générale” (deed in French)
Other provision: “Réputés présents à l'endroit où se tient l'assemblée pour respect des conditions de présence et de majorité, participation à distance par…” (deed in French)
Other provision: “Admission à l'assemblée générale, titulaire de titres nominatifs doit être inscrit en cette qualité dans le registre des titres nominatifs…” (deed in French)
Other provision: “Séances procès-verbaux, liste de présences et rapports éventuels procurations ou votes par correspondance annexés au procès-verbal” (deed in French)
Other provision: “Délibérations assemblée générale, majorité des voix quel que soit nombre titres représentés” (deed in French)
Other provision: “Organe d’administration, 3 semaines” (deed in French)
Other provision: “Pouvoirs conférés par Code des sociétés et des associations, pouvoirs assemblée générale” (deed in French)
Other provision: “Répartition bénéfices-réserves, assemblée générale” (deed in French)
Other provision: “Décider paiement acomptes sur dividendes, acomptes sur dividendes” (deed in French)
Liquidation distribution: “Apurement dettes charges frais ou consignation, proportion actions” (deed in French)
Other provision: “Exécution statuts communications sommations assignations significations, élection de domicile” (deed in French)
Other provision: “Tribunaux du siège, compétence judiciaire” (deed in French)
Other provision: “Droit commun, dispositions Code des sociétés et des associations non licitement dérogées réputées inscrites” (deed in French)
3 more provisions in the deed, see the deed of 06-03-2023

deed of 06-03-2023